Annual EBITDA
-$1.11B$292.00M-35.86%
Summary
- Current Value
- As of today, ROIV annual EBITDA is -$1.11B, down -35.86% on
- Historical Performance
- ROIV annual EBITDA is down -21.47% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- ROIV annual EBITDA is currently -35.86% below its historical high of -$814.35M set on
- 3-Year Low Comparison
- ROIV annual EBITDA is at its 3-year low
- Sector Comparison
- ROIV annual EBITDA is higher than 0.34% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$1.11B | -35.9% | -21.5% | – | – | |
| Quarterly EBITDA | -$338.46M | -24.2% | -23.8% | +7.4% | – | |
| TTM EBITDA | -$1.21B | -17.9% | -26.6% | -231.2% | – | |
| Price | $28.78 | +171.5% | +265.7% | +190.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $29.05M | -11.2% | -47.5% | -57.1% | +1150.1% | |
| Annual EPS | -$0.24 | -104.5% | +81.2% | -104.5% | +95.1% | |
| -$1.11B | -35.0% | +8.1% | -109.2% | -48.8% | ||
| Annual Net Income | -$729.76M | -116.0% | +21.0% | -28.4% | +9.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$814.35M | -35.9% | |
| 5Y | -$814.35M | -35.9% | |
| All | -$814.35M | -35.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.11B | at low | |
| 5Y | -$1.11B | at low | |
| All | -$1.11B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$1.11B | -35.9% | |
| -$814.35M | +22.5% | |
| -$1.05B | -15.4% |
| Year | Value | Change |
|---|---|---|
| -$910.77M | -1.7% | |
| -$895.74M | - |
FAQ
What is the current annual EBITDA of ROIV?
As of today, ROIV annual EBITDA is -$1.11B
What is 1-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -35.86% year-over-year
What is 3-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -21.47% over the past 3 years
How far is ROIV annual EBITDA from its all-time high?
ROIV annual EBITDA is currently -35.86% below its historical high of -$814.35M set on March 31, 2024
How does ROIV annual EBITDA rank versus sector peers?
ROIV annual EBITDA is higher than 0.34% of companies in Healthcare sector
When is ROIV next annual earnings release?
The next annual earnings release for ROIV is on
Quarterly EBITDA
-$338.46M$33.15M-10.86%
Summary
- Current Value
- As of today, ROIV quarterly EBITDA is -$338.46M, down -10.86% on
- Historical Performance
- ROIV quarterly EBITDA is down -24.23% year-over-year, down -23.81% over the past 3 years
- All-Time High Comparison
- ROIV quarterly EBITDA is currently -170.33% below its historical high of -$125.20M set on
- 3-Year Low Comparison
- ROIV quarterly EBITDA is +1.22% above its 3-year low of -$342.63M reached on
- Sector Comparison
- ROIV quarterly EBITDA is higher than 0.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$338.46M | -10.9% | -24.2% | -23.8% | +7.4% | |
| Annual EBITDA | -$1.11B | – | -35.9% | -21.5% | – | |
| TTM EBITDA | -$1.21B | -5.8% | -17.9% | -26.6% | -231.2% | |
| Price | $28.78 | +37.2% | +171.5% | +265.7% | +190.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $2.00M | +27.2% | -77.8% | -88.3% | -86.8% | |
| Quarterly EPS | -$0.38 | -128.9% | -262.8% | +22.7% | +83.3% | |
| -$339.15M | -10.8% | -23.6% | -21.0% | +37.3% | ||
| Quarterly Net Income | -$313.70M | -88.9% | -50.1% | +18.5% | +44.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$272.44M | N/A | -24.2% |
| 3Y | -$201.68M | -67.8% | |
| 5Y | -$125.20M | -170.3% | |
| All | -$125.20M | -170.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$338.46M | at low | |
| 3Y | -$342.63M | +1.2% | |
| 5Y | -$684.43M | +50.5% | |
| All | -$684.43M | +50.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ROIV?
As of today, ROIV quarterly EBITDA is -$338.46M
What is ROIV quarterly EBITDA most recent change?
ROIV quarterly EBITDA was down -10.86% on December 31, 2025
What is 1-year change in ROIV quarterly EBITDA?
ROIV quarterly EBITDA is down -24.23% year-over-year
How far is ROIV quarterly EBITDA from its all-time high?
ROIV quarterly EBITDA is currently -170.33% below its historical high of -$125.20M set on March 31, 2022
How does ROIV quarterly EBITDA rank versus sector peers?
ROIV quarterly EBITDA is higher than 0.64% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
TTM EBITDA
-$1.21B$66.02M-5.77%
Summary
- Current Value
- As of today, ROIV TTM EBITDA is -$1.21B, down -5.77% on
- Historical Performance
- ROIV TTM EBITDA is down -17.87% year-over-year, down -26.62% over the past 3 years
- All-Time High Comparison
- ROIV TTM EBITDA is currently -231.22% below its historical high of -$365.67M set on
- 3-Year Low Comparison
- ROIV TTM EBITDA is at its 3-year low
- Sector Comparison
- ROIV TTM EBITDA is higher than 0.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$1.21B | -5.8% | -17.9% | -26.6% | -231.2% | |
| Annual EBITDA | -$1.11B | – | -35.9% | -21.5% | – | |
| Quarterly EBITDA | -$338.46M | -10.9% | -24.2% | -23.8% | +7.4% | |
| Price | $28.78 | +37.2% | +171.5% | +265.7% | +190.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $13.31M | -34.5% | -56.4% | -69.1% | -12.1% | |
| TTM EPS | -$1.17 | -111.5% | -706.4% | +34.2% | +48.9% | |
| -$1.22B | -5.6% | -17.4% | -25.3% | -124.7% | ||
| TTM Net Income | -$1.01B | -11.6% | -75.8% | +25.3% | -78.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.03B | N/A | -17.9% |
| 3Y | -$832.64M | -45.5% | |
| 5Y | -$365.67M | -231.2% | |
| All | -$365.67M | -231.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.21B | at low | |
| 3Y | -$1.21B | at low | |
| 5Y | -$1.45B | +16.4% | |
| All | -$1.45B | +16.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ROIV?
As of today, ROIV TTM EBITDA is -$1.21B
What is ROIV TTM EBITDA most recent change?
ROIV TTM EBITDA was down -5.77% on December 31, 2025
What is 1-year change in ROIV TTM EBITDA?
ROIV TTM EBITDA is down -17.87% year-over-year
How far is ROIV TTM EBITDA from its all-time high?
ROIV TTM EBITDA is currently -231.22% below its historical high of -$365.67M set on March 31, 2021
How does ROIV TTM EBITDA rank versus sector peers?
ROIV TTM EBITDA is higher than 0.27% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508826000011/0001635088-26-000011-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv